← All organizations

Allakos, Inc.

For profitWebsite ↗

Also known as: Allakos Inc. | Allakos, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 28, 2024

Timeline

2010s

Jun 1, 2012
Allakos, Inc.— Founded

Drugs by trial phase (3 distinct, 18 trials)

Phase 3 (1 own, 0 via acquisition)

Lirentelimab

Phase 2 (1 own, 0 via acquisition)

ak001

Phase 1 (1 own, 0 via acquisition)

ak006

Indications

Studied for

Recent trials (32)

NCT06577116OfficialPhase 1Aug 28, 2024
NCT06577116Lead sponsorPhase 1Aug 28, 2024
NCT06072157Lead sponsorPhase 1Aug 28, 2023
NCT06072157Study directorPhase 1Aug 28, 2023
NCT05528861Lead sponsorPhase 2Oct 26, 2022
NCT05528861Study directorPhase 2Oct 26, 2022
NCT05155085Lead sponsorPhase 2Dec 31, 2021
NCT05152563Study directorPhase 3Dec 31, 2021
NCT05152563Lead sponsorPhase 3Dec 31, 2021
NCT05155085Study directorPhase 2Dec 31, 2021
NCT04856891Lead sponsorPhase 3May 20, 2021
NCT04856891Study directorPhase 3May 20, 2021
NCT04620811Lead sponsorPhase 3Dec 3, 2020
NCT04620811Study directorPhase 3Dec 3, 2020
NCT04322604Lead sponsorPhase 3Mar 31, 2020

Details

Founded: San Carlos, CA, US Jun 1, 2012
Last known activity: Aug 28, 2024